Hypoparathyroidism

Long-Term rhPTH(1-84) Associated With Reduced Need for Calcium, Calcitriol Supplements

Long-Term rhPTH(1-84) Associated With Reduced Need for Calcium, Calcitriol Supplements

By

The therapy was also associated with reduced urinary calcium excretion and stable serum calcium concentration in patients with hypoparathyroidism.

Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

By

PTH (1-84) for 7 years is linked to reduced calcium and calcitriol supplementation.

Natpara Injection Now Available in the U.S.

Natpara Injection Now Available in the U.S.

By

Shire announced the launch of Natpara (parathyroid hormone) for injection indicated as adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism

Natpara Earns FDA Approval for Hypoparathyroidism

Natpara Earns FDA Approval for Hypoparathyroidism

By

The FDA has approved Natpara (parathyroid hormone) to control hypocalcemia in patients with hypoparathyroidism.

Advisory Panel Favors Approval of Natpara

Advisory Panel Favors Approval of Natpara

By

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of recombinant human parathyroid hormone for hypoparathyroidism.

Recombinant Human Parathyroid Hormone Effective for Hypoparathyroidism

Recombinant Human Parathyroid Hormone Effective for Hypoparathyroidism

By

Patients with hypoparathyroidism may benefit from treatment with recombinant human parathyroid hormone.

Sign Up for Free e-Newsletters

CME Focus